Associate Professor, Internal Medicine, University of Michigan Medical School
Nephrology
Dr. Diane M. Cibrik, MD
|
|
Give Review
Diane Cibrik works in the field of Nephrology. She studied medicine at Case Western Reserve University School of Medicine. She received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Diane M. Cibrik is also published. She has 47 publications published. The lastest publication: "Identification of a protein signature in renal allograft rejection.' Diane Cibrik is registered with Medicare and accepts Medicare payments.
Publications
- Identification of a protein signature in Renal allograft rejection.
- Mycophenolic Acid Pharmacokinetics in Lung Transplant Recipients With Cystic Fibrosis.
- A history of chronic opioid usage prior to Kidney transplantation may be associated with increased mortality risk.
- Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation.
- The time interval between Kidney and pancreas transplantation and the clinical outcomes of pancreas after Kidney transplantation.
- Lymphoma after solid organ transplantation: risk, Response to therapy, and survival at a transplantation center.
- Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in Renal transplant recipients with diabetes.
- Impact of simultaneous pancreas and Kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus.
- Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated With mycophenolate mofetil: review of the literature.
- Evaluation of pancreatic allograft dysfunction by laparoscopic biopsy.
- Renal allograft survival in patients with oxalosis.
- Interaction between donor and recipient age in determining the risk of chronic renal allograft Failure.
- Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in Renal-transplant recipients.
- Comparative risk of impaired glucose Metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period.
- Fixed- or controlled-dose mycophenolate mofetil With standard- or reduced-dose calcineurin inhibitors: the Opticept trial.
- Long-term experience with everolimus in Kidney transplantation in the United States.
- Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in Renal transplant recipients.
- Mycophenolate mofetil reduces late renal allograft loss independent of Acute rejection.
- Excellent outcome of renal transplantation in patients with Fabry's Disease.
- Increased immunosuppressive vulnerability in elderly Renal transplant recipients.
- Efficacy of valganciclovir in the treatment of cytomegalovirus disease in Kidney and pancreas transplant recipients.
- The impact of simultaneous pancreas-Kidney transplantation on long-term patient survival.
- Role of anti-interleukin-2 receptor antibodies in Kidney transplantation.
- Survival improvement among patients with end-stage renal Disease: trends over time for transplant recipients and wait-listed patients.
- Long-term benefit of Kidney-pancreas transplants in type 1 diabetics.
- Differences in etiology for graft loss in female Renal transplant recipients.
- Need for individualized immunosuppression in elderly Renal transplant recipients.
- Time to first graft loss as a risk factor for second Renal allograft loss.
- Mycophenolate mofetil decreases the risk for chronic renal allograft Failure.
- Gender differences in the risk for chronic renal allograft Failure.
- Interaction of mycophenolate mofetil and HLA matching on Renal allograft survival.
- Effect of mycophenolate mofetil on long-term outcomes in African american Renal transplant recipients.
- Increased impact of Acute rejection on chronic allograft failure in recent era.
- Renal transplantation at the University of Michigan 1964 to 1999.
- Effect of waiting time on Renal transplant outcome.
- African-American Renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies.
- Relationship of recipient age and development of chronic allograft Failure.
- Immunosuppression: practice and trends.
- Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis.
- Rabbit antithymocyte globulin versus basiliximab in Renal transplantation.
- Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in Renal transplant recipients.
- Randomized controlled trial of FTY720 versus MMF in de novo Renal transplantation.
- Multicenter, randomized study of the use of everolimus with tacrolimus after Renal transplantation demonstrates its effectiveness.
- Influence of recipient race on the outcome of simultaneous pancreas and Kidney transplantation.
- Optimal everolimus concentration is associated with risk reduction for Acute rejection in de novo renal transplant recipients.
- Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus Infection.
Schools
Catholic University Of America
University Hospital Of Cleveland
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1508948407 | |
| NPPES Provider LastName | CIBRIK | |
| NPPES Provider FirstName | DIANE | |
| NPPES Provider ZIPCode | 481095364 | |
| NPPES Provider State | MI | |
| Specialty Description | Nephrology | |
| Total Claim Count | 2202.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508948407 |
| Last Name Of The Provider | CIBRIK |
| First Name Of The Provider | DIANE |
| View All |
Similar Doctors
|
|
Dr. Joseph M. Messana, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yihung Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepa R. Jayaram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Puneet Garg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akinlolu O. Ojo, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Richard D. Swartz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joel M. Weinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christin A. Martin, MD |
|
|
Dr. Daniel E. Lipschutz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crystal A. Gadegbeku, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjeevkumar R. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Delyria, MD |
|
|
Dr. Julie A. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Yan Yang, MB BS |